Mark Agulnik

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Tyrosine Kinase

Monoclonal Antibody

Top Venues

Journal of personalized medicine

JCO oncology practice

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Caleb Hwang, Mark Agulnik, Brian C Schulte
Prices and Trends in FDA-Approved Medications for Sarcomas. Cancers 16 (8) (2024)
Caleb Hwang, Mark Agulnik, Brian C Schulte
Prices and Trends in FDA-Approved Medications for Sarcomas. Cancers 16 (8) (2024)
Natalie K Heater, Scott Okuno, Steven Robinson, Steven Attia, Mahesh Seetharam, Brittany L Siontis, Janet Yoon, Sant Chawla, Mohammed M Milhem, Varun V Monga, Keith M Skubitz, John Charlson, Angela C Hirbe, Mia C Weiss, Brian Andrew Van Tine, Mark Agulnik
The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma. Journal of clinical medicine 12 (7) (2023)
Dana A Dominguez, Sagus Sampath, Mark Agulnik, Yu Liang, Bao Nguyen, Vijay Trisal, Laleh G Melstrom, Aaron G Lewis, Isaac Benjamin Paz, Randall F Roberts, William W Tseng
Surgical Management of Retroperitoneal Sarcoma. Current oncology (Toronto, Ont.) 30 (5) (2023)
Charles S Kamen, Don S Dizon, Chunkit Fung, Mandi L Pratt-Chapman, Mark Agulnik, Lola A Fashoyin-Aje, Sanford E Jeames, Janette K Merrill, Kimberly T Smith, Shail Maingi
State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority Communities. JCO oncology practice (2023)
Adam G Rock, An Uche, Janet Yoon, Mark Agulnik, Warren Chow, Sherri Millis
Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma. Journal of personalized medicine 13 (10) (2023)
Joseph D Femino, Scott C Nelson, Mark Agulnik, Lee M Zuckerman
All-Internal Limb Lengthening with Simultaneous Corrective Osteotomy After Internal Hemipelvectomy: A Case Report. JBJS case connector 12 (2) (2022)
Devon Miller, Jonathan A Livingston, Yeonhee Park, Kristi Posey, Sonia Godbole, Keith M Skubitz, Steven I Robinson, Mark Agulnik, Lara E Davis, Brian Andrew Van Tine, Angela C Hirbe, Amanda Parkes
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy. Cancer medicine 11 (18) (2022)
Sant P Chawla, Brian Andrew Van Tine, Seth M Pollack, Kristen N Ganjoo, Anthony D Elias, Richard F Riedel, Steven Attia, Edwin Choy, Scott H Okuno, Mark Agulnik, Margaret von Mehren, Michael B Livingston, Vicki L Keedy, Claire F Verschraegen, Tony Philip, G Chet Bohac, Sergey Yurasov, Adam Yakovich, Hailing Lu, Michael Chen, Robert G Maki
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Brian Schulte, Nisha Mohindra, Mohammed Milhem, Steven Attia, Steven Robinson, Varun Monga, Angela C Hirbe, Peter Oppelt, John Charlson, Irene Helenowski, Susan Abbinanti, Rasima Cehic, Scott Okuno, Brian A Van Tine, Mark Agulnik
Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. British journal of cancer 125 (4) (2021)
Jason P Lambden, Max F Kelsten, Brian C Schulte, Susan Abbinanti, John P Hayes, Victoria Villaflor, Mark Agulnik
Metastatic Myxofibrosarcoma with Durable Response to Temozolomide Followed by Atezolizumab: A Case Report. The oncologist 26 (7) (2021)
Jonathan Moreira, Alexander Tobias, Michael P O'Brien, Mark Agulnik
Targeted Therapy in Head and Neck Cancer: An Update on Current Clinical Developments in Epidermal Growth Factor Receptor-Targeted Therapy and Immunotherapies. Drugs 77 (8) (2017)